Pharma & Biotech News , from our Global Correspondents
Refine Search
Pharmaceutical
The Russian government may consider the possibility of beginning public procurements of prescription drugs with their further provision to local population, according to recent statements, made by representatives of the Ministry of Health, reports The Pharma Letter’s local correspondent 5 November 2019
Pharmaceutical
Sales of drugs in Russian pharmacies during the period of January-September 2019 fell by 1.5% in volume terms to 3.8 billion packages, marking the first sales’ decline in the Russian pharmaceutical retail since 2015, according to recent statistics, published by the Russian Ministry of Health and various local analyst agencies, reports The Pharma Letter’s local correspondent. 5 November 2019
Pharmaceutical
Even as a new vaccine is set to change the face of tuberculosis prevention, the TB Alliance has given the green light to Indian company Macleods Pharmaceuticals to manufacture the drug pretomanid, used to treat highly drug-resistant TB and as part of a regimen along with bedaquiline and linezolid, reports The Pharma Letter’s India correspondent. 31 October 2019
Pharmaceutical
Independent French drugmaker Servier plans to accelerate its expansion both in the domestic market and abroad within the next several years, that will mainly take place through the expansion of the already existing range and the launch of production of new drugs. 29 October 2019
Pharmaceutical
German drugmaker Stada Arzneimittel will start the production of at least four of its drugs at the facilities of its Russian subsidiary Nizhpharm in the Russian city of Nizhny Novgorod in 2021, according to recent statements made by Deputy General Director of STADA CIS Ivan Glushkov, reports The Pharma Letter’s local correspondent. 29 October 2019
Pharmaceutical
Amid the forthcoming introduction of new rules for re-registration of prices for vital drugs in Russia and associated with this the increase of costs, global drugmakers operating in Russia are looking for ways to optimize their Russian business, reports The Pharma Letter’s local correspondent. 22 October 2019
Pharmaceutical
Leading domestic and global pharmaceutical producers operating in the Russian market plan to expand their cooperation with local medical personnel during the promotion of their drugs in Russia, by organizing more scientific conferences, and active invitation of doctors to participate in them, according to recent statements by drugmakers and industry analysts, reports The Pharma Letter’s local correspondent. 22 October 2019
Pharmaceutical
Rare growth disorders can be the result of various genetic mutations, environmental factors such as malnutrition, abnormalities in bone and cartilage development, or secondary to chronic illness. 21 October 2019
Pharmaceutical
In recent years, the US Food and Drug Administration has taken several steps to better position itself to support medical innovation. Still, the director of the Administration’s Center for Drug Evaluation and Research (CDER), Dr Janet Woodcock, has recently criticized certain research practices that she feels frustrates the progress of innovation. 18 October 2019
Generics
The signs are clear that India is seeing a big rise in pharmaceutical R&D investment, reports The Pharma Letter’s India correspondent. 17 October 2019
Generics
Russian drugmakers are considering more active foreign expansion that will be in the form of larger exports of their products, according to recent statements of producers and industry analysts, reports The Pharma Letter’s local correspondent. 15 October 2019
Pharmaceutical
Despite new launches dropping abysmally, India’s pharmaceutical market has grown at its fastest pace in more than a year in the quarter ended September given higher volumes and prices. According to data from market research agency AIOCD-AWACS, the Indian pharma market expanded 11.5% for the quarter ended September 30. 10 October 2019
Pharmaceutical
The share of public procurement in the overall structure of drug sales in Russian pharmaceutical market has reached 34.4% in the first half of 2019, which became a historical record figure for the country and its pharmaceutical market since the collapse of the USSR, according to a recent study, conducted by DSM Group, one of Russia’s leading pharma analysts, reports The Pharma Letter’s local correspondent 7 October 2019
Pharmaceutical
All actors in the health system in Latin America – academia, industry representatives, patient associations, suppliers and customers, health authorities and health technology assessment (HTA) agencies – must work together to achieve better conditions for patients. 3 October 2019
Pharmaceutical
As the incurable Duchenne muscular dystrophy (DMD), a rare genetic disease, takes a heavy toll of children in India, the Ministry of Health and Family Welfare has given instructions to speed up the process of formulating the National Policy for treatment of Rare Diseases, reports The Pharma Letter’s India correspondent. 1 October 2019
Pharmaceutical
More than 700 drugs have disappeared from the Russian pharmaceutical market since the beginning of the current year, according to recent statements by officials of the Russian Ministry of Health and industry’s analysts, reports The Pharma Letter’s local correspondent. 30 September 2019
Biotechnology
Swiss pharma giant Roche has officially announced localization of two of its innovative drugs in Russia at the facilities of its local partners, reports The Pharma Letter’s local correspondent. 30 September 2019
Pharmaceutical
Global pharmaceutical companies hope to increase their share of public procurements in Russia as soon as this year, thanks to the new methodology on the formation of the initial maximum price for state contracts, which has been recently introduced by the Russian Ministry of Health, reports The Pharma Letter’s local correspondent. 23 September 2019
Pharmaceutical
UK pharma major GlaxoSmithKline has signed an agreement with Russian drugmaker Nanolek on the localization of vaccine production in Russia by 2021, according to recent statements of the companies, reports The Pharma Letter’s local correspondent. 23 September 2019
Pharmaceutical
Heavy rains across several parts of India have provided a shot in the arm for anti-infective drugs that have been on the decline for the past several months. The category of anti-infective drugs grew at 15.3% year-on-year in August, compared to the Indian pharmaceutical market growth of 9.4%, reports The Pharma Letter’s India correspondent. 23 September 2019
Pharmaceutical
Big pharmas are not deterred by China’s increasingly complex business environment. Instead, they are changing strategies to minimize risks while continuing to benefit from China, said speakers at ChinaTrials held last week in Shanghai. 18 November 2024
Generics
Indian drugmaker Aurobindo Pharma has taken on the might of China in terms of Penicillin G pricing, and is doing so by leveraging a fully integrated production process at its new plant. Anticipating the price erosion of Penicillin G, the company has put up an integrated plant from scratch. 10 November 2024
Generics
Indian markets are abuzz with a singular refrain. Donald Trump's Presidency of the United States is set to open new opportunities for India, especially in the pharmaceutical sector. 8 November 2024
Biotechnology
According to UNICEF's State of the World's Children 2023 report, in Latin America
and the Caribbean, 6.8 million children did not benefit from vaccination during the
time of the pandemic and in the following two years, progress has not been as
expected either. 7 November 2024
Biotechnology
As India's bioeconomy soars to a remarkable valuation of $151 billion, the government's Biotechnology Industry Research Assistance Council (BIRAC) has underscored the critical need for innovation and private sector investment to unlock further growth. 21 October 2024
Biotechnology
India's new Biotechnology Research Innovation and Entrepreneurship Development (Bio-RIDE) scheme is a significant step towards consolidating and advancing the country's biotechnology initiative. 7 October 2024
Pharmaceutical
India is set to complete 50 new greenfield pharma manufacturing plants in the next two years under its Production-linked Incentive (PLI) scheme for pharma and medical devices. 30 September 2024
Generics
The number of clinical trials of new drugs in Russia is steadily declining, which could be mainly related with the overall reduction of investment activities in the local pharmaceutical market, reports The Pharma Letter’s local correspondent. 30 September 2024
Pharmaceutical
Pharmaceutical laboratories, institutions, guilds and medical federations have taken on the task of designing programs to end health illiteracy in order to have informed, educated, knowledgeable and empowered communities where their health and wellbeing are concerned. 19 September 2024
Pharmaceutical
Oligonucleotide therapeutics are rapidly emerging as a promising class of drugs capable of addressing a variety of genetic and complex diseases by targeting RNA sequences.1 16 September 2024
Generics
The protection of intellectual property (IP) rights of foreign pharmaceutical companies in Russia remains complex situation, according to recent statements by Konstantin Panurovsky, legal director of AstraZeneca’s Russian subsidiary, reports The Pharma Letter’s local correspondent. 13 September 2024
Pharmaceutical
The Russian Ministry of Health wants to speed registration of drugs that are not localized in the Russian Federation at the time of the application submitted by domestic pharmaceutical companies, explaining such changes by "unpredictable geopolitical situation," reports The Pharma Letter’s local correspondent. 12 September 2024
Biotechnology
NewCo, a relatively new business model that involves a joint venture (JV) between a biotech and a group of investors to bring the biotech’s promising assets to the global market, is gaining popularity among Chinese biotechs, who traditionally rely on out-licensing deals to capitalize assets, s 11 September 2024
Generics
A significant drop has been noticed in the prices of active pharmaceutical ingredients (APIs), bringing much-needed relief to the pharmaceutical industry and potentially translating to lower drug costs for consumers. 9 September 2024
Biotechnology
Targeted alpha therapy (TAT), or radioligand therapy, is a recent hot area that attracted big pharmas like Bristol Myers Squibb and Novartis. 5 September 2024
Generics
German pharma major Bayer has filed a lawsuit against the Russian drugmaker Promomed to protect the patent rights for Xarelto (rivaroxaban), its treatment for stroke prevention which is the best-selling drug in the Russian market at present, The Pharma Letter’s local correspondent reports. 2 September 2024
Pharmaceutical
Scientists from the Russian Institute of Immunology of the Federal Medical and Biological Agency (FMBA) say they have created the world's first allergy vaccine. 30 August 2024
Generics
In a major crackdown, the Indian government has imposed an immediate ban on 156 fixed-dose combination (FDC) drugs, including commonly used antibiotics, pain relievers,and multivitamins. 27 August 2024
Pharmaceutical
Russia plans to create conditions for a significant increase of domestic production of anti-Rhesus immunoglobulin drugs after a sharp decrease of their imports to the local market this year, reports The Pharma Letter’s local correspondent. 22 August 2024
Generics
One of the largest pharmaceutical production facilities in the Russian North-West region will soon be built in the city of Pushkino by the local drugmaker Active Component enterprise, The Pharma Letter’s local correspondent reports. 14 August 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze